+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 390 Pages
  • Global
From
From
From
Oncolytic Virus Therapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy - Global Strategic Business Report

  • Report
  • November 2026
  • 483 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 380 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report 2026 - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 211 Pages
  • Global
From
From
Immuno-Oncology - Global Strategic Business Report 2026 - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 246 Pages
  • Global
From
From
Urothelial Cancer Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 126 Pages
  • Global
From
Cancer Immunotherapy - Global Strategic Business Report 2026 - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 291 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 233 Pages
  • Global
From
Bispecific Antibody Cancer Therapy Market Global Report 2026 - Product Thumbnail Image

Bispecific Antibody Cancer Therapy Market Global Report 2026

  • Report
  • April 2026
  • 250 Pages
  • Global
From
Checkpoint Inhibitor Refractory Cancer Market Report 2026 - Product Thumbnail Image

Checkpoint Inhibitor Refractory Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2026 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
CTLA4 Inhibitors Market Report 2026 - Product Thumbnail Image

CTLA4 Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
PD-1 Resistant Head and Neck Cancer Market Report 2026 - Product Thumbnail Image

PD-1 Resistant Head and Neck Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Malignant Mesothelioma Market Report 2026 - Product Thumbnail Image

Malignant Mesothelioma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more